The First Hydroxylated Archazolid from the Myxobacterium Cystobacter violaceus: Isolation, Structural Elucidation and V-ATPase Inhibition

The First Hydroxylated Archazolid from the Myxobacterium Cystobacter violaceus: Isolation, Structural Elucidation and V-ATPase Inhibition Archazolid‐7‐<i>O</i>‐β‐<scp>D</scp>‐glucopyranoside – Isolation, Structural Elucidation and Solution Conformation of a Novel V‐ATPase Inhibitor from the Myxobacterium <i>Cystobacter violaceus</i> Archazolid A-15-<i>O</i>-β-<scp>d</scp>-glucopyranoside and <i>iso</i>-Archazolid B: Potent V-ATPase Inhibitory Polyketides from the Myxobacteria <i>Cystobacter violaceus</i> and <i>Archangium gephyra</i> Archazolid A-15-<i>O</i>-β-<scp>d</scp>-glucopyranoside and <i>iso</i>-Archazolid B: Potent V-ATPase Inhibitory Polyketides from the Myxobacteria <i>Cystobacter violaceus</i> and <i>Archangium gephyra</i> Archazolids, New Cytotoxic Macrolactones from Archangium gephyra (Myxobacteria) Production, Isolation, Physico-chemical and Biological Properties Design, synthesis, and biological evaluation of novel analogues of archazolid: A highly potent simplified V-ATPase inhibitor Synthesis of Novel Potent Archazolids: Pharmacology of an Emerging Class of Anticancer Drugs Synthesis and biological evaluation of a water-soluble derivative of the potent V-ATPase inhibitor archazolid New Benzoxazine Secondary Metabolites from an Arctic Actinomycete New Benzoxazine Secondary Metabolites from an Arctic Actinomycete